Perspective Therapeutics (CATX) Cash & Current Investments (2010 - 2026)
Perspective Therapeutics' Cash & Current Investments came in at $236.9 million for Q2 2026, up 23.6% from $191.6 million a year earlier but down 12.6% from the prior quarter.
Perspective Therapeutics (CATX) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Perspective Therapeutics' Cash & Current Investments was $144.7 million, down 36.2% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 127.2% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $226.9 million in FY2024, $8,000 in FY2023 (-100.0%), $43.76 million in FY2022 and $63.83 million in FY2021.
- The five-year range for quarterly Cash & Current Investments is $8,000 (Q4 2023) to $292.9 million (Q2 2024).
- Year-over-year, Cash & Current Investments increased in three of the last six quarters, with an average decline of 6.2%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2024 (growth of 934.3%), and the weakest in Q4 2023 (a decline of 100.0%).
- Business Quant data shows CATX's Cash & Current Investments at $270.9 million (Q1 2026), $144.7 million (Q4 2025) and $174.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Perspective Therapeutics | 193.05 Mn | -43.85 Mn | - | 236.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 236.90 Mn |
| Mar 31, 2026 | 270.90 Mn |
| Dec 31, 2025 | 144.70 Mn |
| Sep 30, 2025 | 174.10 Mn |
| Jun 30, 2025 | 191.60 Mn |
| Mar 31, 2025 | 211.70 Mn |
| Dec 31, 2024 | 226.90 Mn |
| Sep 30, 2024 | 267.80 Mn |
| Jun 30, 2024 | 292.90 Mn |
| Mar 31, 2024 | 180.65 Mn |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 17.98 Mn |
| Jun 30, 2023 | 28.32 Mn |
| Mar 31, 2023 | 36.45 Mn |
| Dec 31, 2022 | 43.76 Mn |
| Sep 30, 2022 | 54.11 Mn |
| Jun 30, 2022 | 55.89 Mn |
| Mar 31, 2022 | 58.90 Mn |
| Dec 31, 2021 | 60.35 Mn |
| Sep 30, 2021 | 61.69 Mn |
Perspective Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CATX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();